NO320587B1 - Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat. - Google Patents

Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat. Download PDF

Info

Publication number
NO320587B1
NO320587B1 NO20015148A NO20015148A NO320587B1 NO 320587 B1 NO320587 B1 NO 320587B1 NO 20015148 A NO20015148 A NO 20015148A NO 20015148 A NO20015148 A NO 20015148A NO 320587 B1 NO320587 B1 NO 320587B1
Authority
NO
Norway
Prior art keywords
polymorph
compound
polymorph according
diabetes mellitus
solution
Prior art date
Application number
NO20015148A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015148D0 (no
NO20015148L (no
Inventor
Robert Gordon Giles
Stephen Moore
Paul David James Blackler
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en
Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20015148D0 publication Critical patent/NO20015148D0/no
Publication of NO20015148L publication Critical patent/NO20015148L/no
Publication of NO320587B1 publication Critical patent/NO320587B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO20015148A 1999-04-23 2001-10-22 Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat. NO320587B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909471.6A GB9909471D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912195.6A GB9912195D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001522 WO2000064893A2 (en) 1999-04-23 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (3)

Publication Number Publication Date
NO20015148D0 NO20015148D0 (no) 2001-10-22
NO20015148L NO20015148L (no) 2001-12-17
NO320587B1 true NO320587B1 (no) 2005-12-27

Family

ID=26315459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015148A NO320587B1 (no) 1999-04-23 2001-10-22 Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat.

Country Status (36)

Country Link
EP (2) EP1175418A2 (hr)
JP (1) JP2002543076A (hr)
KR (1) KR100744361B1 (hr)
CN (1) CN1152878C (hr)
AP (1) AP1607A (hr)
AR (2) AR023560A1 (hr)
AU (2) AU4307200A (hr)
BG (1) BG65517B1 (hr)
BR (1) BR0009935A (hr)
CA (1) CA2370262A1 (hr)
CO (1) CO5170419A1 (hr)
CZ (1) CZ20013801A3 (hr)
DZ (1) DZ3164A1 (hr)
EA (1) EA003031B1 (hr)
EG (1) EG23937A (hr)
GC (1) GC0000250A (hr)
HK (1) HK1045152A1 (hr)
HR (1) HRP20010774A2 (hr)
HU (1) HUP0200937A3 (hr)
IL (1) IL146115A0 (hr)
MA (1) MA26786A1 (hr)
MX (1) MXPA01010822A (hr)
MY (1) MY138673A (hr)
NO (1) NO320587B1 (hr)
NZ (1) NZ515167A (hr)
OA (1) OA11873A (hr)
PE (1) PE20010045A1 (hr)
PL (1) PL351685A1 (hr)
SK (1) SK14932001A3 (hr)
TR (1) TR200103060T2 (hr)
TW (1) TWI288749B (hr)
UA (1) UA67845C2 (hr)
UY (1) UY26119A1 (hr)
WO (1) WO2000064893A2 (hr)
YU (1) YU75401A (hr)
ZA (1) ZA200108718B (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
EP1690940A1 (en) * 1999-04-13 2006-08-16 The Government of the United States of America as Represented by The Department of Health and Human Services Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
US6806280B1 (en) 1999-04-23 2004-10-19 Smithkline Beecham P.L.C. Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt
KR100744359B1 (ko) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (en) * 2003-01-08 2004-07-29 Dr. Reddy's Laboratories Limited Amorphous form of rosiglitazone maleate and process for preparation thereof
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW201336497A (zh) * 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd 噻唑啶二酮化合物之結晶型及其製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AR023560A1 (es) 2002-09-04
MXPA01010822A (es) 2002-06-04
ZA200108718B (en) 2002-12-03
SK14932001A3 (sk) 2002-02-05
GC0000250A (en) 2006-11-01
CA2370262A1 (en) 2000-11-02
MY138673A (en) 2009-07-31
CZ20013801A3 (cs) 2002-07-17
NZ515167A (en) 2004-02-27
HK1045152A1 (zh) 2002-11-15
AR023750A1 (es) 2002-09-04
WO2000064893A2 (en) 2000-11-02
PE20010045A1 (es) 2001-03-10
NO20015148D0 (no) 2001-10-22
BG106122A (en) 2002-05-31
EA003031B1 (ru) 2002-12-26
KR100744361B1 (ko) 2007-07-30
AU2755102A (en) 2002-05-16
JP2002543076A (ja) 2002-12-17
EP1277753A1 (en) 2003-01-22
AP2001002329A0 (en) 2001-12-31
NO20015148L (no) 2001-12-17
WO2000064893A3 (en) 2001-01-25
YU75401A (sh) 2004-09-03
BR0009935A (pt) 2002-04-16
KR20010110804A (ko) 2001-12-13
DZ3164A1 (fr) 2000-11-02
CN1152878C (zh) 2004-06-09
OA11873A (en) 2006-03-27
MA26786A1 (fr) 2004-12-20
BG65517B1 (bg) 2008-10-31
EG23937A (en) 2008-01-14
TR200103060T2 (tr) 2002-05-21
CO5170419A1 (es) 2002-06-27
AU4307200A (en) 2000-11-10
UY26119A1 (es) 2000-12-29
AP1607A (en) 2006-05-03
AU771342B2 (en) 2004-03-18
HRP20010774A2 (en) 2002-10-31
CN1355800A (zh) 2002-06-26
EA200101122A1 (ru) 2002-04-25
UA67845C2 (uk) 2004-07-15
EP1175418A2 (en) 2002-01-30
IL146115A0 (en) 2002-07-25
TWI288749B (en) 2007-10-21
HUP0200937A3 (en) 2004-03-29
PL351685A1 (en) 2003-06-02
HUP0200937A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
NO320574B1 (no) Polymorf av 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion-maleinsyresalt, anvendelse og fremgangsmate for fremstilling derav samt farmasoytisk preparat.
NO320589B1 (no) Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat.
NO317255B1 (no) Substituert tiazolidinderivat, fremgangsmate for fremstilling og anvendelse derav
NO320587B1 (no) Polymorf, anvendelse og fremstilling derav, samt farmasoytisk preparat.
NO317254B1 (no) 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt-hydrat som farmasoytikum
NO317253B1 (no) Hydrat av 5-[-4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion-maleinsyre-salt
US7358366B2 (en) Thiazolidinedione derivative and its use as antidiabetic
NO320609B1 (no) Hydroklorid-hydrat, anvendelse og fremstilling derav, samt farmasoytisk preparat.
NO320573B1 (no) Hydroklorid-hydrater, anvendelse og fremstilling derav, samt farmasoytisk preparat.